| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Sung Joon Cho, Min-Kyoung Kim, Seong Yun Bang, Minji Bang, Sang-Hyuk Le. White matter integrity associated with severity reductions in positive symptoms after amisulpride treatment in drug-free patients with schizophrenia. Neuroscience letters. vol 685. 2019-03-07. PMID:30157448. |
white matter integrity associated with severity reductions in positive symptoms after amisulpride treatment in drug-free patients with schizophrenia. |
2019-03-07 |
2023-08-13 |
human |
| Sung Joon Cho, Min-Kyoung Kim, Seong Yun Bang, Minji Bang, Sang-Hyuk Le. White matter integrity associated with severity reductions in positive symptoms after amisulpride treatment in drug-free patients with schizophrenia. Neuroscience letters. vol 685. 2019-03-07. PMID:30157448. |
amisulpride is an effective antipsychotic for the treatment of schizophrenia with a lower propensity for extrapyramidal adverse effects than conventional antipsychotics. |
2019-03-07 |
2023-08-13 |
human |
| Sung Joon Cho, Min-Kyoung Kim, Seong Yun Bang, Minji Bang, Sang-Hyuk Le. White matter integrity associated with severity reductions in positive symptoms after amisulpride treatment in drug-free patients with schizophrenia. Neuroscience letters. vol 685. 2019-03-07. PMID:30157448. |
however, no study has investigated white matter (wm) integrity in patients with schizophrenia in relation to treatment response after amisulpride administration. |
2019-03-07 |
2023-08-13 |
human |
| Sung Joon Cho, Min-Kyoung Kim, Seong Yun Bang, Minji Bang, Sang-Hyuk Le. White matter integrity associated with severity reductions in positive symptoms after amisulpride treatment in drug-free patients with schizophrenia. Neuroscience letters. vol 685. 2019-03-07. PMID:30157448. |
here, we investigated the associations of wm integrity with severity reductions in clinical symptoms in drug-free patients with schizophrenia at an early stage of amisulpride treatment. |
2019-03-07 |
2023-08-13 |
human |
| Marwa H Shukr, Omar A Ahmed Fari. Amisulpride-CD-Loaded Liposomes: Optimization and In Vivo Evaluation. AAPS PharmSciTech. vol 19. issue 6. 2018-10-18. PMID:29943282. |
amisulpride (ams) is an atypical antipsychotic agent used for the treatment of schizophrenia. |
2018-10-18 |
2023-08-13 |
Not clear |
| Li-Juan Gao, Hua-Gui Guo, Zhen-Tao Liang, Xiao-Xiao Zhong, Jin-Cai Zhu, Yu Yan. [Aripiprazole for drug-induced sexual dysfunction in schizophrenic males]. Zhonghua nan ke xue = National journal of andrology. vol 23. issue 7. 2018-10-12. PMID:29723454. |
to investigate the clinical effects of aripiprazole on sexual dysfunction induced by amisulpride or risperidone in male patients with schizophrenia. |
2018-10-12 |
2023-08-13 |
Not clear |
| Seung-Gul Kang, Ik-Seung Chee, Hun Soo Chang, Kyoung-Sae Na, Kwanghun Lee, Jonghun Le. Polymorphism of the SNAP25 gene is associated with symptom improvement in schizophrenic patients treated with amisulpride. Neuroscience letters. vol 661. 2018-07-26. PMID:28947383. |
thus, the present study investigated the associations between polymorphisms of snap25 and the treatment response to amisulpride in patients with schizophrenia. |
2018-07-26 |
2023-08-13 |
human |
| Thomas Re Barnes, Verity C Leeson, Carol Paton, Louise Marston, Linda Davies, William Whittaker, David Osborn, Raj Kumar, Patrick Keown, Rameez Zafar, Khalid Iqbal, Vineet Singh, Pavel Fridrich, Zachary Fitzgerald, Hemant Bagalkote, Peter M Haddad, Mariwan Husni, Tim Amo. Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness. Health technology assessment (Winchester, England). vol 21. issue 49. 2018-06-04. PMID:28869006. |
amisulpride augmentation in clozapine-unresponsive schizophrenia (amicus): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness. |
2018-06-04 |
2023-08-13 |
Not clear |
| Manu Arora, Rakesh Banal, Samir K Praharaj, Vivek Mahaja. Amisulpride Augmentation in Acute Catatonia. American journal of therapeutics. vol 24. issue 4. 2018-04-06. PMID:26270797. |
amisulpride is one of the atypical antipsychotic that has been effective for negative symptoms of schizophrenia. |
2018-04-06 |
2023-08-13 |
Not clear |
| Seung-Gul Kang, Ik-Seung Chee, Kwanghun Lee, Jonghun Le. rs7968606 polymorphism of ANKS1B is associated with improvement in the PANSS general score of schizophrenia caused by amisulpride. Human psychopharmacology. vol 32. issue 2. 2017-12-25. PMID:28332719. |
rs7968606 polymorphism of anks1b is associated with improvement in the panss general score of schizophrenia caused by amisulpride. |
2017-12-25 |
2023-08-13 |
human |
| Seung-Gul Kang, Ik-Seung Chee, Kwanghun Lee, Jonghun Le. rs7968606 polymorphism of ANKS1B is associated with improvement in the PANSS general score of schizophrenia caused by amisulpride. Human psychopharmacology. vol 32. issue 2. 2017-12-25. PMID:28332719. |
the aim of this study was to determine the association between the rs7968606 snp of anks1b and the treatment response to amisulpride in schizophrenia patients. |
2017-12-25 |
2023-08-13 |
human |
| Seung-Gul Kang, Ik-Seung Chee, Kwanghun Lee, Jonghun Le. rs7968606 polymorphism of ANKS1B is associated with improvement in the PANSS general score of schizophrenia caused by amisulpride. Human psychopharmacology. vol 32. issue 2. 2017-12-25. PMID:28332719. |
to the best of our knowledge, this is the first genetic association study of the relationship between the rs7968606 snp of anks1b and the response of schizophrenia patients to treatment with amisulpride. |
2017-12-25 |
2023-08-13 |
human |
| Alper Bas, Gozde Gultekin, Said Incir, Tuba Ocek Bas, Murat Emul, Alaatin Dura. Level of serum thioredoxin and correlation with neurocognitive functions in patients with schizophrenia using clozapine and other atypical antipsychotics. Psychiatry research. vol 247. 2017-11-17. PMID:27871032. |
the aim of this study is investigating the relationship between serum thioredoxin levels and cognitive functions in acute psychotic episode and remission state patients with schizophrenia; and examining whether there were differences between patients using clozapine and other atypical antipsychotics; including risperidone, olanzapine and amisulpride. |
2017-11-17 |
2023-08-13 |
Not clear |
| Stephan Heres, Diana Meliu Cirjaliu, Liana Dehelean, Valentin Petre Matei, Delia Marina Podea, Dorina Sima, Lynne Stecher, Stefan Leuch. The SWITCH study: rationale and design of the trial. European archives of psychiatry and clinical neuroscience. vol 266. issue 6. 2017-02-03. PMID:26227799. |
in the switch trial, 350 patients suffering from an acute episode of schizophrenia are randomly assigned to double-blind treatment with either olanzapine or amisulpride. |
2017-02-03 |
2023-08-13 |
Not clear |
| Ying Liang, Changan Cao, Cheng Zhu, Chuanyue Wang, Congpei Zhang, Fang Dong, Fude Yang, Hong Deng, Jingjie Yu, Jisheng Tang, Lei Su, Limin Xin, Ling Hong, Minglong Gao, Muni Tang, Shiping Xie, Shuiping Lu, Tiebang Liu, Xiaojin Xu, Xijin Wang, Xuanzi Li, Xueyi Wang, Yi Li, Yong Zhang, Zhiyu Chen, Xin Y. The effectiveness and safety of amisulpride in Chinese patients with schizophrenia: An 8-week, prospective, open-label, multicenter, single-arm study. Asia-Pacific psychiatry : official journal of the Pacific Rim College of Psychiatrists. vol 8. issue 3. 2017-01-30. PMID:27020720. |
the effectiveness and safety of amisulpride in chinese patients with schizophrenia: an 8-week, prospective, open-label, multicenter, single-arm study. |
2017-01-30 |
2023-08-13 |
Not clear |
| Ying Liang, Changan Cao, Cheng Zhu, Chuanyue Wang, Congpei Zhang, Fang Dong, Fude Yang, Hong Deng, Jingjie Yu, Jisheng Tang, Lei Su, Limin Xin, Ling Hong, Minglong Gao, Muni Tang, Shiping Xie, Shuiping Lu, Tiebang Liu, Xiaojin Xu, Xijin Wang, Xuanzi Li, Xueyi Wang, Yi Li, Yong Zhang, Zhiyu Chen, Xin Y. The effectiveness and safety of amisulpride in Chinese patients with schizophrenia: An 8-week, prospective, open-label, multicenter, single-arm study. Asia-Pacific psychiatry : official journal of the Pacific Rim College of Psychiatrists. vol 8. issue 3. 2017-01-30. PMID:27020720. |
this study evaluated the effectiveness and safety of amisulpride in chinese schizophrenia patients. |
2017-01-30 |
2023-08-13 |
Not clear |
| Pallavi Sinha, Amit Gar. Use of amisulpride in treating adolescent onset schizophrenia associated with stuttering priapism induced by multiple antipsychotics. Asian journal of psychiatry. vol 19. 2016-12-19. PMID:26957345. |
use of amisulpride in treating adolescent onset schizophrenia associated with stuttering priapism induced by multiple antipsychotics. |
2016-12-19 |
2023-08-13 |
Not clear |
| Signe Düring, Birte Yding Glenthøj, Bob Oranj. Effects of Blocking D2/D3 Receptors on Mismatch Negativity and P3a Amplitude of Initially Antipsychotic Naïve, First Episode Schizophrenia Patients. The international journal of neuropsychopharmacology. vol 19. issue 3. 2016-12-13. PMID:26453696. |
this is the first study investigating the effect of amisulpride, a potent d2-antagonist, on mismatch negativity and p3a amplitude in a large group of antipsychotic-naïve, first-episode schizophrenia patients. |
2016-12-13 |
2023-08-13 |
Not clear |
| Chun-Yen Chen, Yi-Wei Yeh, Shin-Chang Kuo, Pei-Shen Ho, Chih-Sung Liang, Che-Hung Yen, Ru-Band Lu, San-Yuan Huan. Catechol-O-methyltransferase gene variants may associate with negative symptom response and plasma concentrations of prolactin in schizophrenia after amisulpride treatment. Psychoneuroendocrinology. vol 65. 2016-12-13. PMID:26724569. |
catechol-o-methyltransferase gene variants may associate with negative symptom response and plasma concentrations of prolactin in schizophrenia after amisulpride treatment. |
2016-12-13 |
2023-08-13 |
human |
| Chun-Yen Chen, Yi-Wei Yeh, Shin-Chang Kuo, Pei-Shen Ho, Chih-Sung Liang, Che-Hung Yen, Ru-Band Lu, San-Yuan Huan. Catechol-O-methyltransferase gene variants may associate with negative symptom response and plasma concentrations of prolactin in schizophrenia after amisulpride treatment. Psychoneuroendocrinology. vol 65. 2016-12-13. PMID:26724569. |
the aim of this study was to examine the relationship between comt variants, plasma prolactin level, and the therapeutic effectiveness of amisulpride treatment in patients with schizophrenia. |
2016-12-13 |
2023-08-13 |
human |